切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2019, Vol. 06 ›› Issue (01) : 1 -8. doi: 10.3877/cma.j.issn.2095-8757.2019.01.001

所属专题: 专题评论 文献 指南共识

指南与共识

血管衰老临床评估与干预中国专家共识(2018)
中华医学会老年医学分会心血管学组   
  • 收稿日期:2019-12-28 出版日期:2019-02-28

Expert consensus on clinical assessment and intervention of vascular aging in China

Geriatric Cardiology Group of Chinese Geriatric Society   

  • Received:2019-12-28 Published:2019-02-28
引用本文:

中华医学会老年医学分会心血管学组. 血管衰老临床评估与干预中国专家共识(2018)[J]. 中华老年病研究电子杂志, 2019, 06(01): 1-8.

Geriatric Cardiology Group of Chinese Geriatric Society. Expert consensus on clinical assessment and intervention of vascular aging in China[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2019, 06(01): 1-8.

表1 动脉粥样硬化和动脉硬化的比较
[1]
Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease[J]. J Physiol, 2016, 594(8):2061-2073.
[2]
Tian XL, Li Y. Endothelial cell senescence and age-related vascular diseases[J]. J Genet Genomics, 2014, 41(9):485-495.
[3]
Cunha PG, Boutouyrie P, Nilsson PM, et al. Early vascular ageing (EVA): definitions and clinical applicability[J]. Curr Hypertens Rev, 2017, 13(1):8-15.
[4]
O'Rourke MF, Safar ME, Dzau V. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature[J]. Vasc Med, 2010, 15(6): 461-468.
[5]
Cunha PG, Cotter J, Oliveira P, et al. Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging[J]. J Hypertens, 2015, 33(7):1438-1445.
[6]
Palombo C, Kozakova M. Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications[J]. Vascul Pharmacol, 2016, 77(2):1-7.
[7]
Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling[J]. N Engl J Med, 1994, 330(20): 1431-1438.
[8]
Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease[J]. Circulation, 2003, 107(2):346-354.
[9]
张乐,张存泰.血管钙化和血管老化[J].中华老年医学杂志,2016,35(10):1046-1050.
[10]
Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality[J]. JACC Cardiovasc Imaging, 2010, 3(12):1229-1236.
[11]
Coylewright M, Rice K, Budoff MJ, et al. Differentiation of severe coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis[J]. Atherosclerosis, 2011, 219(2):616-622.
[12]
Hou ZH, Lu B, Gao Y, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiacevents in outpatients[J]. JACC Cardiovasc Imaging, 2012, 5(10):990-999.
[13]
Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events[J]. JAMA, 2014, 311(3):271-278.
[14]
Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography[J]. J Am Coll Cardiol, 1990, 15(4):827-832.
[15]
Wang M, Kim SH, Monticone RE, et al. Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis[J]. Hypertension, 2015, 65(4):698-703.
[16]
Safar ME. Arterial stiffness as a risk factor for clinical hypertension[J]. Nat Rev Cardiol, 2018, 15(2):97-105.
[17]
Chen W, Li S, Fernandez C, et al. Temporal relationship between elevated blood pressure and arterial stiffening among middle-aged black and white adults: The bogalusa heart study[J]. Am J Epidemiol, 2016, 183(7):599-608.
[18]
Niiranen TJ, Kalesan B, Hamburg NM, et al. Relative contributions of arterial stiffness and hypertension to cardiovascular disease: the Framingham heart study[J]. J Am Heart Assoc, 2016, 5(11):1-8.
[19]
周剑辉,赵权辉,于俊杏,等.臂踝动脉脉搏波传导速度与慢性肾脏病的关系[J].中华高血压杂志,2017,25(4):363-369.
[20]
Sedaghat S, Mattace-Raso FU, Hoorn EJ, et al. Arterial stiffness and decline in kidney function[J]. Clin J Am Soc Nephrol, 2015, 10(12):2190-2197.
[21]
Kong X, Ma X, Tang L, et al. Arterial stiffness evaluated by carotid-femoral pulse wave velocity increases the risk of chronic kidney disease in a Chinese population-based cohort[J]. Nephrology (Carlton), 2017, 22(3):205-212.
[22]
Briet M, Boutouyrie P, Laurent S, et al. Arterial stiffness and pulse pressure in CKD and ESRD[J]. Kidney Int, 2012, 82(4):388-400.
[23]
Safar ME, London GM, Plante GE. Arterial stiffness and kidney function[J]. Hypertension, 2004, 43(2):163-168.
[24]
Georgianos PI, Sarafidis PA, Lasaridis AN. Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients[J]. Curr Vasc Pharmacol, 2015, 13(2):229-238.
[25]
Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension[J]. Stroke, 2003, 34(5):1203-1206.
[26]
van Sloten TT, Sedaghat S, Laurent S, et al. Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis[J]. J Am Coll Cardiol, 2015, 66(19):2116-2125.
[27]
Gasecki D, Rojek A, Kwarciany M, et al. Aortic stiffness predicts functional outcome in patients after ischemic stroke[J]. Stroke, 2012, 43(2):543-544.
[28]
Blum A, Vaispapir V, Keinan-Boker L, et al. Endothelial dysfunction and procoagulant activity in acute ischemic stroke[J]. J Vasc Interv Neurol, 2012, 5(1):33-39.
[29]
Hanon O, Haulon S, Lenoir H, et al. Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss[J]. Stroke, 2005, 36(10):2193-2197.
[30]
van Sloten TT, Stehouwer CD. Carotid stiffness: A novel cerebrovascular disease risk factor[J]. Pulse (Basel), 2016, 4(1):24-27.
[31]
Xu Y, Wu Y, Li J, et al. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients[J]. Hypertens Res, 2008, 31(6):1079-1085.
[32]
Kals J, Lieberg J, Kampus P, et al. Prognostic impact of arterial stiffness in patients with symptomatic peripheral arterial disease[J]. Eur J Vasc Endovasc Surg, 2014, 48(3):308-315.
[33]
Kojima I, Ninomiya T, Hata J, et al. A low ankle brachial index is associated with an increased risk of cardiovascular disease: the Hisayama study[J]. J Atheroscler Thromb, 2014, 21(9):966-973.
[34]
Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries[J]. N Engl J Med, 1986, 315(17):1046-1051.
[35]
Agabiti-Rosei E, Mancia G, O'Rourke MF, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document[J]. Hypertension, 2007, 50(1):154-160.
[36]
D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study[J]. Circulation, 2008, 117(6):743-753.
[37]
Khoshdel AR, Thakkinstian A, Carney SL, et al. Estimation of an age-specific reference interval for pulse wave velocity: a meta-analysis[J]. J Hypertens, 2006, 24(7):1231-1237.
[38]
李珊珊,张存泰,周洪莲,等.脉搏波传导速度与心血管危险因素及Framingham积分的相关性[J].中华老年多器官疾病杂志,2012,11(12):912-916.
[39]
陶杰,李冬青,董岩,等.静息心率与臂踝脉搏波传导速度的关系[J].中华心血管病杂志,2014,42(8):686-692.
[40]
Xu Y, Arora RC, Hiebert BM, et al. Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis[J]. Eur Heart J Cardiovasc Imaging, 2014, 15(7):736-746.
[41]
Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women[J]. J Am Coll Cardiol, 1994, 24(2):471-476.
[42]
Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force[J]. J Am Coll Cardiol, 2002, 39(2):257-265.
[43]
王妍,陶军,杨震,等.肿瘤坏死因子促进内皮细胞微颗粒释放的实验研究[J].中华心血管病杂志,2005,33(12):1137-1140.
[44]
Xia WH, Li J, Su C, et al. Physical exercise attenuates age-associated reduction in endothelium-reparative capacity of endothelial progenitor cells by increasing CXCR4/JAK-2 signaling in healthy men[J]. Aging Cell, 2012, 11(1):111-119.
[45]
陶军,王妍,杨震,等.年龄相关的循环内皮祖细胞变化与动脉弹性关系的研究[J].中华心血管病杂志,2005,33(4):347-350.
[46]
Tao J, Wang Y, Yang Z, et al. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age[J]. J Hum Hypertens, 2006, 20(7):490-495.
[47]
Yan J, Wang J, Huang H, et al. Fibroblast growth factor 21 delayed endothelial replicative senescence and protected cells from H2O2-induced premature senescence through SIRT1[J]. Am J Transl Res, 2017, 9(10):4492-4501.
[48]
Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study[J]. Circulation, 2012, 125(1):130-139.
[49]
李蔚,赵权辉,于俊杏,等.体质量指数与臂踝动脉脉搏波传导速度的关系[J].中华高血压杂志,2017,15(1):49-54.
[50]
黄葵,张存泰.血管老化概述[J].中华老年医学杂志,2016,35(10):1030-1033.
[51]
Fiuza-Luces C, Garatachea N, Berger NA, et al. Exercise is the real polypill[J]. Physiology (Bethesda), 2013, 28(5):330-358.
[52]
Namvaran F, Azarpira N, Rahimi-Moghaddam P, et al. Polymorphism of peroxisome proliferator-activated receptor gamma (PPARgamma) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes[J]. Eur J Pharmacol, 2011, 671(1-3):1-6.
[53]
Kawabe J, Ushikubi F, Hasebe N. Prostacyclin in vascular diseases. Recent insights and future perspectives[J]. Circ J, 2010, 74(5):836-843.
[54]
Lievre M, Morand S, Besse B, et al. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group[J]. Circulation, 2000, 102(4):426-431.
[55]
Arai T. Long-term effects of beraprost sodium on arteriosclerosis obliterans: a single-center retrospective study of Japanese patients[J]. Adv Ther, 2013, 30(5):528-540.
No related articles found!
阅读次数
全文


摘要